Synthesis and antimicrobial activity of novel thiazolidinones

Arkivoc

Volumn 2005, Issue 2, 2005, Pages 46-59

  Sattigeri, Viswajanani J ^a   Soni, Ajay ^a   Singhal, Smita ^a   Khan, Seema ^a   Pandya, Manisha ^a   Bhateja, Pragya ^a   Mathur, Tarun ^a   Rattan, Ashok ^a   Khanna, Jag Mohan ^a   Mehta, Anita ^a  

^a RANBAXY RESEARCH LABORATORIES   (India)

Author keywords

Antimicrobial activity; Iodo cyclothiocarbamation; Thiazolidin 2 one; Thiazolidine 2 thione

Indexed keywords

3 (3 FLUORO 4 MORPHOLIN 4 YLPHENYL) 5 (IODOMETHYL) 1,3 THIAZOLIDINE 2 THIONE; 3 (3 FLUORO 4 MORPHOLIN 4 YLPHENYL) 5 METHYL 1,3 THIAZOL 2(3H) THIONE; 3 (3 FLUORO 4 MORPHOLIN 4 YLPHENYL) 5 METHYLENE 1,3 THIAZOLIDINE 2 THIONE; 5 (AMINOMETHYL) 3 PHENYL 1,3 THIAZOLIDINE 2 THIONE; 5 (AZIDOMETHYL) 3 (3 FLUORO 4 MORPHOLIN 4 YLPHENYL) 1,3 THIAZOLIDINE 2 THIONE; 5 (AZIDOMETHYL) 3 PHENYL 1,3 THIAZOLIDINE 2 THIONE; 5 (IODOMETHYL) 3 PHENYL 1,3 THIAZOLIDINE 2 THIONE; 5 METHYL 3 PHENYL 1,3 THIAZOLE 2(3H) THIONE; 5 METHYLENE 3 PHENYL 1,3 THIAZOLIDINE 2 THIONE; LINEZOLID; N [(2 OXO 3 PHENYL 1,3 THIAZOLIDIN 5 YL)METHYL]ACETAMIDE; N [(3 PHENYL 2 THIOXO 1,3 THIAZOLIDIN 5 YL)METHYL]ACETAMIDE; S [[3 (3 FLUORO 4 MORPHOLIN 4 YLPHENYL) 2 OXO 1,3 OXAZOLIDIN 5 YL]METHYL]ETHANETHIOATE; S [[3 (3 FLUORO 4 MORPHOLIN 4 YLPHENYL) 2 OXO 1,3 THIAZOLIDIN 5 YL]METHYL]ETHANETHIOATE; S [[3 (3 FLUORO 4 MORPHOLIN 4 YLPHENYL) 2 THIOXO 1,3 THIAZOLIDIN 5 YL]METHYL]ETHANETHIOATE; THIAZOLE DERIVATIVE; THIAZOLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CHEMICAL PROCEDURES; CHEMICAL REACTION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; NONHUMAN; REACTION ANALYSIS;

EID: 15444375640     PISSN: 14246376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Cohen, M. L. Nature 2000, 406, 762.
2. Brickner, S. J. Curr. Pharm. Design 1996, 2, 175.
3. (a). Barbachyn, M. R.; Brickner, S. J.; Cleek, G. J.; Gadwood, R. C.; Grega, K. C.; Hendges, S. K.; Hutchinson, D. K.; Manninen, P. R.; Munesada, K.; Thomas, R. C.; Thomasco, L. M.; Toops, D. S.; Ulanowicz, D. A. In Antiinfectives: Recent advances in Chemistry and Structure Activity Relationships, P.H. Bentley, O'Hanlon, Eds., The Royal Society of Chemistry, Hartnolls Limited: Bodmin, Cornwall, 1997, pp 15-26.
4. (b). Barbachyn, M. R.; Brickner, S. J; Gadwood, R. C.; Garmon, S. A.; Grega, K. C.; Hutchinson, D. K.; Munesada, K.; Reischer, R. J.; Taniguchi, M.; Thomasco, L. M.; Toops, D. S.; Yamada, H.; Ford, C. W.; Zurenko, G. E. In Resolving the Antibiotics Paradox, Rosen, B. P.; Mobashery, S.; Eds., Kluwer Academic, Plenum Publishers: New York, 1998, pp 219-240.
5. Shinabarger, D. A. Exp. Opin. Invest. Drugs 1999, 8, 1195. Chem. Abstr. 1999, 131, 269300.
6. Shinabarger, D. A. Exp. Opin. Invest. Drugs 1999, 8, 1195. Chem. Abstr. 1999, 131, 269300.
7. Fugitt, R. B.; Luckenbaugh, R. W. Eur. Pat. Appln. 1982, EP 50,827. Chem. Abstr. 1982, 97, 109990.
8. (a). Lizondo, J; Rabasseda, X; Castaner, J. Drugs of Future 1996, 21, 1116.
9. (b). Moellering Jr., R. C. Ann. Intern. Med. 2003, 138, 135.
10. Mehta, A; Arora, S. K.; Das, B.; Ray, A.; Rudra, S.; Rattan, A. Oxazolidinone derivatives as antimicrobials, WIPO Pat. Appln. 2002, WO 02/06278. Chem. Abstr. 2002, 136, 134748.
11. Gordeev, M. F. Current Opinion in Drug Discovery and Development, 2001, 4, 450.
12. Singh, S. P.; Parmar, S. S.; Raman, K.; Sternberg, V. I. Chem. Rev. 1981, 81, 175.
13. Seneci, P.; Caspani, M.; Ripamonti, F.; Ciabatti, R. J. Chem. Soc., Perkin Trans I 1994, 2345.
14. Creeke, P.I.; Mellor, J.M. Tetrahedron Lett., 1989, 30, 4435.
15. (a). Georges, M.; MacKay, D; Fraser-Reid, B. J. Am. Chem. Soc. 1982, 104, 1101.
16. (b). Grega, K. C.; Barbachyn, M. R.; Brickner, S. J.; Mizsak, S. A. J. Org. Chem. 1995, 60, 5255.
17. Bayley, H.; Standring, D. N.; Knowles, J. R. Tetrahedron Lett. 1978, 3633.
18. Calo, V.; Nacci, A.; Volpe, A. Gazz. Chim. Ital., 1997, 127, 283.
19. Brickner, S. J.; Hutchinson, D. K.; Barbachyn, M. R.; Manninen, P. R.; Ulanowicz, D. A.; Garmon, S. A.; Grega, K. C.; Hendges, S. K.; Toops, D. S.; Ford, C. W.; Zurenko, G. E. J. Med. Chem. 1996, 39, 673.
20. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically Fifth edition. Approved standard. NCCLS Document M7-A5, 20, No. 2, NCCLS, Wayne, PA, January 2000.
21. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard. NCCLS Document M27-A, 17, 1-29, NCCLS, Wayne, PA, 1997.
22. National Committee for Clinical Laboratory Standards. Reference Method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi; Proposed Standard, NCCLS document M38-P. NCCLS, Wayne, PA, 1998.